Lobbying Filing Details

Total Spending

$130,000

Activities

1

Lobbyists

1

Gov't Entities

3

Filing Information
Filing UUID:
f233b819-af1b-4261-ba51-e1b785f4ee18
Type:
Q1 - 1st Quarter - Report
Period:
2022 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2022 at 5:19 PM
Income:
$0
Expenses:
$130,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Andrew Womack
Registrant
IGM BIOSCIENCES, INC.

​Development of engineered IgM antibodies

Mountain View, California
Client
IGM BIOSCIENCES, INC.
California, United States of America
Lobbying Activities (1)
Activity 1
Medical/Disease Research/Clinical Labs

H.R.2471 - Consolidated Appropriations Act, 2022 COVID Supplemental Appropriation FY2023 Defense Appropriations S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-19 Issues related to antimicrobial resistance (AMR) and drug development Issues related to supply chain and biopharmaceutical manufacturing

Lobbyists (1)
  • MR. ANDREW WESLEY WOMACK
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 11, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.